EXAGEN INC.

(XGN)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
4.780 USD   +14.35%
05/16Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus
GL
05/16Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus
AQ
05/16Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on EXAGEN INC.
05/13KeyBanc Lowers Exagen's Price Target to $17 From $20, Maintains Overweight Rating
MT
03/25KeyBanc Adjusts Exagen's Price Target to $20 From $30, Reiterates Overweight Rating
MT
03/23Cowen Adjusts Exagen's Price Target to $16 from $26, Reiterates Outperform Rating
MT
2021KeyBanc Adjusts Price Target on Exagen to $30 from $33, Keeps Overweight Rating
MT
2021EXAGEN : BTIG Adjusts Exagen's Price Target to $20 From $23, Reiterates Buy Rating
MT
2021EXAGEN : Canaccord Genuity Initiates Exagen at Buy Rating With $25 Price Target
MT
2020EXAGEN : KeyBanc Initiates Exagen at Overweight with $32 Price Target
MT
Upcoming event on EXAGEN INC.